ELIZABETH PHAM: Open Payments
NPI 1366193120 · DOWNEY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,004 in 122 payments from 40 companies in 2025. Trend: 2023 $0 · 2024 $4,060 · 2025 $4,004
Food & beverage: $2,590Long term medical supply or device loan: $848Education: $566
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 15 | $949 |
| Janssen Biotech, Inc. | 13 | $450 |
| SOBI, INC | 5 | $244 |
| Merck Sharp & Dohme LLC | 7 | $167 |
| Astellas Pharma US Inc | 4 | $165 |
| SEAGEN INC. | 2 | $161 |
| ABBVIE INC. | 7 | $151 |
| PFIZER INC. | 9 | $145 |
| BeOne Medicines USA, Inc. | 5 | $144 |
| Daiichi Sankyo Inc. | 5 | $136 |
Products named: KISQALI, ERLEADA, KEYTRUDA, BRUKINSA, Enhertu, Nubeqa, OPDIVO, Vyloy.
Industry payments across CA — which companies pay providers there.
